QuantHealth

QuantHealth is a privately held technology company specializing in AI-driven clinical trial simulation, headquartered in Tel Aviv, Israel, with additional operations in New York. Founded in 2020, the company's core mission is to transform healthcare by accelerating the development of groundbreaking therapies, aiming to bring more effective treatments to patients faster and more affordably.

The company's primary offering is an AI-driven simulation platform that enables pharmaceutical and biotechnology companies to evaluate, optimize, and de-risk clinical trials before patient enrollment. This platform simulates patient responses to various therapies, allowing for the refinement of trial design, indication selection, and overall development strategies. QuantHealth's solutions support decision-making across the entire drug development lifecycle, from initial planning to market positioning.

QuantHealth has established itself as a global leader in its field, having simulated over 600 clinical trials across 30 indications with up to 90% predictive accuracy. The company is a trusted partner to 12 of the top 20 global pharmaceutical companies. In August 2026, QuantHealth secured $45 million in Series B funding, led by Qumra Capital, bringing its total funding to approximately $70-75 million. Orr Inbar serves as the Co-founder and CEO, with Arnon Horev as Co-founder and Chief Strategy & Operations Officer.